InvestorsHub Logo
Followers 52
Posts 9087
Boards Moderated 1
Alias Born 10/25/2007

Re: reyprimero post# 13128

Friday, 12/15/2023 12:38:22 AM

Friday, December 15, 2023 12:38:22 AM

Post# of 13457
the Keynote-942/mRNA-4157-P201 study was the first demonstration of efficacy for an investigational mRNA cancer treatment in a randomized clinical trial and the first combination therapy to show a significant benefit over Keytruda alone in adjuvant melanoma!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRNA News